The prevalence and disease course of autoimmune liver diseases in Greenland

References

• EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015;63(4):971–7. doi: 10.1016/j.jhep.2015.06.030
   PubMed Web of Science ®Google Scholar
• EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237–267. doi: 10.1016/j.jhep.2009.04.009
   PubMed Web of Science ®Google Scholar
• Karlsen TH, Folseraas T, Thorburn D, et al. Primary sclerosing cholangitis - a comprehensive review. J Hepatol. 2017;67(6):1298–1323. doi: 10.1016/j.jhep.2017.07.022
   PubMed Web of Science ®Google Scholar
• Czaja AJ. Autoimmune hepatitis in diverse ethnic populations and geographical regions. Expert Rev Gastroenterol Hepatol. 2013;7(4):365–385. doi: 10.1586/egh.13.21
   PubMed Web of Science ®Google Scholar
• Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand. 1980;208(5):401–406. doi: 10.1111/j.0954-6820.1980.tb01221.x
   PubMedGoogle Scholar
• Harvald B. Genetic epidemiology of Greenland. Clin Genet. 1989;36(5):364–367. doi: 10.1111/j.1399-0004.1989.tb03214.x
   PubMed Web of Science ®Google Scholar
• Noahsen P, Rex KF, Bülow Pedersen I, et al. Thyroid autoimmunity in Greenlandic Inuit. Eur Thyroid J. 2022;11(3). doi: 10.1530/ETJ-22-0071
   PubMed Web of Science ®Google Scholar
• Pedersen ML, Bjerregaard P, Jørgensen ME. GAD65 antibodies among Greenland Inuit and its relation to glucose intolerance. Acta Diabetol. 2014;51(4):641–646. doi: 10.1007/s00592-014-0569-z
   PubMed Web of Science ®Google Scholar
• Gantzel RH, Vesterdal JD, Haase A-M, et al. The prevalence of inflammatory bowel disease in Greenland. Inflamm Bowel Dis. Published online January 2023;29(12):1879–1885. doi: 10.1093/ibd/izad002
   PubMed Web of Science ®Google Scholar
• Hurlburt KJ, McMahon BJ, Deubner H, et al. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterology. 2002;97(9):2402–2407. doi: 10.1111/j.1572-0241.2002.06019.x
   PubMed Web of Science ®Google Scholar
• Johnston JM, McMahon B, Townshend-Bulson L, et al. Autoimmune hepatitis and overlap syndrome among Alaska native people: prevalence, clinical characteristics, and remission. JGH Open An Open Access J Gastroenterol Hepatol. 2023;7(8):545–552. doi: 10.1002/jgh3.12946
   PubMed Web of Science ®Google Scholar
• Grønbæk L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014;60(3):612–617. doi: 10.1016/j.jhep.2013.10.020
   PubMed Web of Science ®Google Scholar
• Boberg KM, Aadland E, Jahnsen J, et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998;33(1):99–103. doi: 10.1080/00365529850166284
   PubMed Web of Science ®Google Scholar
• Marschall H-U, Henriksson I, Lindberg S, et al. Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort. Sci Rep. 2019;9(1):11525. doi: 10.1038/s41598-019-47890-2
   PubMedGoogle Scholar
• Pedersen ML. Microvascular complications in Nuuk, Greenland, among greenlanders and non-greenlanders diagnosed with type 2 diabetes. Diabet Res Clin Pract. 2018;136:1–6. doi: 10.1016/j.diabres.2017.11.030
   PubMed Web of Science ®Google Scholar
• Nielsen MT, Hykkelbjerg Nielsen M, Andersen S, et al. Quality of care among patients diagnosed with atrial fibrillation in Greenland. International Journal Of Circumpolar Health. 2024;83(1):2311965. doi: 10.1080/22423982.2024.2311965
   PubMed Web of Science ®Google Scholar
• Botvid SHC, Storgaard Hove L, Sauer Mikkelsen C, et al. Patterns in contacts with primary health care centres in Greenland. International Journal Of Circumpolar Health. 2023;82(1):2217007. doi: 10.1080/22423982.2023.2217007
   PubMed Web of Science ®Google Scholar
• Okkes IM, Becker HW, Bernstein RM, et al. The March 2002 update of the electronic version of ICPC-2. A step forward to the use of ICD-10 as a nomenclature and a terminology for ICPC-2. Fam Pract. 2002;19(5):543–546. doi: 10.1093/fampra/19.5.543
   PubMed Web of Science ®Google Scholar
• World Health Organisation. 2004. ICD-10: international statistical classification of diseases and related health problems: tenth revision. https://apps.who.int/iris/handle/10665/42980
   Google Scholar
• Kumagi T, Guindi M, Fischer SE, et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol. 2010;105(10):2186–2194. doi: 10.1038/ajg.2010.216
   PubMed Web of Science ®Google Scholar
• Muhammad AG, Hansen FO, Gantzel RH, et al. Non-alcoholic fatty liver disease in patients with type 2 diabetes in Greenland: a register-based cross-sectional study. Int J Of Cir Health. 2022;81(1):2065755. doi: 10.1080/22423982.2022.2065755
   PubMed Web of Science ®Google Scholar
• Greenland Statistics. [cited 2023 Nov 8]. Available from: https://bank.stat.gl/pxweb/en/Greenland/
   Google Scholar
• Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Stat Sci. 2001;16(2):101–133. doi: 10.1214/ss/1009213286
   Web of Science ®Google Scholar
• Tanaka A. Autoimmune hepatitis: 2019 update. Gut Liver. 2020;14(4):430–438. doi: 10.5009/gnl19261
   PubMed Web of Science ®Google Scholar
• Nielsen KR, Midjord J, Johannesen HL, et al. A nationwide study of autoimmune liver diseases in the Faroe Islands: Incidence, prevalence, and causes of death 2004 - 2021. Int J Of Cir Health. 2023;82(1):2221368. doi: 10.1080/22423982.2023.2221368
   PubMed Web of Science ®Google Scholar
• Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56(5):1181–1188. doi: 10.1016/j.jhep.2011.10.025
   PubMed Web of Science ®Google Scholar
• Lleo A, Jepsen P, Morenghi E, et al. Evolving trends in female to male incidence and male mortality of primary biliary cholangitis. Sci Rep. 2016;6(1):25906. doi: 10.1038/srep25906
   PubMedGoogle Scholar
• Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol. 2008;14(21):3368–3373. doi: 10.3748/wjg.14.3368
   PubMed Web of Science ®Google Scholar
• Chazouillères O, Wendum D, Serfaty L, et al. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol. 2006;44(2):400–406. doi: 10.1016/j.jhep.2005.10.017
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Myers RP, Barkema HW, et al. Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population-based study. Liver Int Off J Int Assoc Study Liver. 2011;31(5):712–720. doi: 10.1111/j.1478-3231.2011.02484.x
   PubMed Web of Science ®Google Scholar
• Rokkjaer MS, Jensen MT, Grønbaek H, et al. Discharge diagnoses of liver diseases in Nuuk Greenland compared to a Danish county hospital. Int J Of Cir Health. 2006;65(2):162–168. doi: 10.3402/ijch.v65i2.18094
   PubMed Web of Science ®Google Scholar
• Gantzel RH, Villadsen GE, Rex KF, et al. Signs of non-alcoholic fatty liver disease in indigenous Arctic populations - a systematic review. Dan Med J. 2023;70(5).
   PubMed Web of Science ®Google Scholar